Rheumatology Therapeutics Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the rheumatology therapeutics market size evolved in recent years?
The market for rheumatology therapeutics has been on a steady upward trajectory in the past few years. Starting from a valuation of $42.4 billion in 2024, it is projected to ascend to $44.61 billion in 2025, charting an impressive compound annual growth rate (CAGR) of 5.2%. The dynamic growth seen during this period is linked to several factors – a surge in the occurrence of rheumatologic conditions, a globally aging population, increased cognizance of available treatments, progress in biological therapies, and amplified healthcare reach in burgeoning markets.
What are the predictions for the rheumatology therapeutics market size in the coming years?
The rheumatology therapeutics market size is expected to see steady growth in the next few years. It will grow to $53.88 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to the shift towards personalized medicine approaches, rising adoption of biosimilars in rheumatology, increasing investment in research and development, integration of digital health technologies, and regulatory approvals for novel therapies. Major trends in the forecast period include growth in telemedicine and remote monitoring solutions, expansion of targeted therapies for specific rheumatic conditions, emphasis on patient-centric care models, expansion of biologic treatments beyond monoclonal antibodies, and adoption of value-based pricing models.
Get your rheumatology therapeutics market report here!
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
What key factors are fueling the growth of the rheumatology therapeutics market?
The increase in autoimmune diseases is predicted to stimulate the expansion of the rheumatology therapeutics market. Autoimmune diseases, in which the body’s immune system erroneously harms its own tissues, are witnessing a surge due to a mix of genetic, environmental, and lifestyle influences, along with heightened awareness and enhanced diagnostic skills. Rheumatology therapeutics are essential for treating these diseases to manage inflammation, relieve symptoms, and prevent damage to joints and tissue from the body’s own immune system attack. For example, the Australian Institute of Health and Welfare, a government agency in Australia, reported that approximately 514,000 people in Australia, accounting for 2.0% of the population, were expected to have rheumatoid arthritis by 2022. By 2023, rheumatoid arthritis represented 2.0% of the overall disease load and 16% of the total burden related to all musculoskeletal conditions. As a result, the increasing incidence of autoimmune diseases is fueling the development of the rheumatology therapeutics market.
How is the global rheumatology therapeutics market divided into key segments?
The rheumatology therapeutics market covered in this report is segmented –
1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications
Subsegments:
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp
Who are the key firms paving the way for growth in the rheumatology therapeutics market?
Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.
What emerging trends are influencing the growth of the rheumatology therapeutics market?
Leading firms in the rheumatology therapeutics market are pioneering the creation of inventive solutions like intravenous (IV) formulations to boost both the effectiveness of the treatment and patient ease. The term intravenous (IV) formulation pertains to medications or substances administered right into the vein via a catheter or needle. For example, Novartis AG, a pharmaceutical company originating from Switzerland, reported in October 2023 that Cosentyx, an IV formulation, gained approval from the US Food and Drug Administration (FDA). This particular variant of Cosentyx has been exclusively approved to provide treatment for adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). Its mechanism of action involves targeting and inhibiting interleukin-17A (IL-17A) specifically, distinguishing it as the solo non-tumor necrosis factor alpha (TNF-a) IV therapy accessible for these ailments.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246
What regions are contributing significantly to the growth of the rheumatology therapeutics market?
North America was the largest region in the rheumatology therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cystic Fibrosis (CF) Therapeutics Global Market Report 2024
Hepatitis Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report
Peptide Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
